Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic (semaglutide) gained attention for weight loss, but it is formally approved only for managing blood sugar in people with type 2 diabetes. The active ingredient—semaglutide—has demonstrated significant metabolic benefits in clinical research, and many people explore this medication for weight management. PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies, making GLP-1 therapy accessible nationwide without insurance requirements.

Understanding Ozempic and Its Actual FDA Indication

Ozempic is a branded semaglutide injection manufactured by Novo Nordisk and carries FDA approval specifically for type 2 diabetes treatment. The medication works by stimulating GLP-1 receptors in the pancreas and brain, which regulate blood sugar and appetite signaling. Off-label use of Ozempic for weight loss has increased dramatically, but this use falls outside its approved indication.

Wegovy is the branded weight-loss formulation of semaglutide also made by Novo Nordisk, and it carries FDA approval for chronic weight management. However, Wegovy often faces supply constraints and high out-of-pocket costs even with insurance. Many patients seeking GLP-1 therapy for weight loss turn to compounded alternatives that deliver the same active pharmaceutical ingredient at lower cost and with consistent availability.

How Compounded Semaglutide Differs from Branded Ozempic

Compounded semaglutide is manufactured by licensed 503A compounding pharmacies under strict pharmaceutical standards and quality control. These facilities follow USP (United States Pharmacopeia) guidelines and state pharmacy regulations to ensure sterility, potency, and purity. The active ingredient is identical to that in Ozempic and Wegovy, but compounding allows for personalized dosing and lower pricing without the markup of branded pharmaceutical distribution.

PlexusDx partners exclusively with licensed 503A compounding pharmacies—never 503B facilities—to source semaglutide injections. The compounding model eliminates intermediary markups, allowing pricing to start at $149 per month regardless of your starting dose. This flat-rate structure means your dose can increase as your treatment progresses without your monthly cost changing, a model branded medications cannot match.

The Science Behind Semaglutide for Weight Loss

Semaglutide activates GLP-1 receptors throughout the body, triggering a cascade of metabolic responses: reduced appetite signaling in the hypothalamus, delayed stomach emptying, improved insulin sensitivity, and decreased energy intake. Clinical trials have shown that patients using semaglutide achieve weight reductions of 10–22% of body weight over 68 weeks, significantly exceeding results from diet and exercise alone.

Beyond weight loss, semaglutide improves cardiovascular markers, including blood pressure and triglyceride levels, in individuals with obesity. Research published in peer-reviewed journals demonstrates sustained benefits at 2-year follow-up, indicating that GLP-1 therapy produces durable metabolic improvement rather than temporary weight loss.

How PlexusDx Makes GLP-1 Therapy Accessible and Personalized

PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays. Compounded semaglutide injections start at $149 per month across three commitment tiers, and your monthly cost remains fixed even as your healthcare provider adjusts your dose upward over time. The platform also accepts HSA and FSA contributions, reducing your net out-of-pocket expense.

PlexusDx offers an optional Precision Peptide Genetic Test ($99 add-on after your first month of treatment) that maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights relevant to GLP-1 response. The test identifies key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313, helping your provider predict which therapy and dosing strategy will work best for your unique biology. This precision approach moves beyond one-size-fits-all treatment.

Common Questions About Accessing Semaglutide for Weight Loss

Many patients ask whether they can use Ozempic off-label or whether compounded semaglutide is medically equivalent. Compounded semaglutide contains the same FDA-approved active pharmaceutical ingredient and is produced under rigorous pharmacy standards. Your healthcare provider can legally prescribe compounded semaglutide for weight loss, and PlexusDx handles all coordination between you, your provider, and the compounding pharmacy.

Cost and access are major barriers to GLP-1 therapy in the United States. Branded Wegovy often costs $900–$1,500 per month with insurance, and many plans deny coverage. PlexusDx compounded semaglutide starts at $149 per month with no insurance requirement, making GLP-1 therapy financially feasible for patients who would otherwise face prohibitive expenses. The monthly price never increases with dose escalation, removing a major source of treatment anxiety.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide the same as Ozempic or Wegovy?

Compounded semaglutide contains the same active pharmaceutical ingredient as both Ozempic and Wegovy. The difference is manufacturing origin—compounded versions come from licensed 503A pharmacies rather than large pharmaceutical manufacturers. Efficacy and safety are equivalent, but compounded options offer consistent availability and lower cost.

What does the clinical evidence say about semaglutide for weight loss?

Randomized controlled trials demonstrate that semaglutide produces average weight loss of 10–22% of body weight over 68 weeks, compared to 2–3% with lifestyle changes alone. Benefits persist at long-term follow-up, and cardiovascular improvements (lower blood pressure, improved lipid profiles) accompany weight reduction in most patients.

How much does PlexusDx semaglutide cost, and does my dose affect pricing?

PlexusDx compounded semaglutide injections start at $149 per month and remain flat across three commitment tiers. Your dose may increase as your treatment progresses, but your monthly price will not change—a pricing model branded medications cannot offer. PlexusDx also accepts HSA and FSA contributions.

Are there side effects I should know about with semaglutide?

Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and temporary as your body adjusts. Serious but rare complications include pancreatitis and gallbladder issues. Your PlexusDx provider will monitor you throughout treatment and can adjust dosing if side effects emerge.

What is the Precision Peptide Genetic Test, and how does it help?

The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 150+ genetic insights to predict your individual response to GLP-1 therapy. It identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and weight loss potential, allowing your provider to personalize your t...

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves